You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國際醫學(000516.SZ)上半年預虧3.52億元-3.62億元
格隆匯 07-09 18:31

格隆匯7月9日丨國際醫學(000516.SZ)披露2021年半年度業績預吿,公司預計2021年1-6月實現歸屬於上市公司股東的淨利潤為虧損3.52億元-3.62億元,上年同期為虧損3.44億元。2021年半年度業績虧損主要原因是:

1.2021年上半年,公司旗下三大綜合性醫療院區西安高新醫院、西安國際醫學中心醫院、商洛國際醫學中心醫院實現全面投用,醫療服務業務整體規模有效擴大,門診量、住院量、營業收入同比大幅增長。伴隨各新建醫療項目陸續投用,行業影響力提升,公司整體醫療牀位使用量處於快速提升階段,運營成本、期間費用相較於營業收入依然處於較高水平。

2.公司持有的交易性金融資產報吿期內公允價值變動收益對公司淨利潤影響約為-7124萬元;公司2021年上半年實施限制性股票激勵計劃,並完成授予登記,報吿期產生費用對公司淨利潤影響約為-3127萬元。報吿期歸屬於上市公司股東的扣除非經常性損益的淨利潤較上年同期持續減虧,幅度明顯。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account